Comparison of nebulised salbutamol and ipratropium bromide with salbutamol alone in the treatment of chronic obstructive pulmonary disease.
about
Anticholinergic bronchodilators versus beta2-sympathomimetic agents for acute exacerbations of chronic obstructive pulmonary diseaseGlobal burden of COPDSimilarities and discrepancies between exacerbations of asthma and chronic obstructive pulmonary disease.Can we justify ipratropium therapy as initial management of acute exacerbations of COPD?Chronic obstructive pulmonary disease exacerbations: latest evidence and clinical implications.Inhaled short-acting beta2-agonists versus ipratropium for acute exacerbations of chronic obstructive pulmonary disease.Management of acute exacerbations of chronic obstructive pulmonary disease.Management of an acute exacerbation of copd: are we ignoring the evidence?Chronic obstructive pulmonary disease . 6: The aetiology of exacerbations of chronic obstructive pulmonary diseaseCOPD exacerbations.5: management.Pharmacological treatment of chronic obstructive pulmonary disease.Inhaled albuterol/salbutamol and ipratropium bromide and their combination in the treatment of chronic obstructive pulmonary disease.What is in the guidelines about the pharmacological treatment of chronic obstructive pulmonary disease?Nebulisers for chronic obstructive pulmonary disease.The efficacy of nebulized albuterol/ipratropium bromide versus albuterol alone in the prehospital treatment of suspected reactive airways disease.
P2860
Q24250271-183B3D5B-DD0D-48DA-98EE-5A3B7AFECC1BQ26780363-7013B52A-08EB-4746-8CE6-B0F95CBCF037Q33630448-65F5695E-60BF-4259-A024-8148C33122D7Q33693824-6D5F1249-0D3E-4B3D-A8C8-E93ECAF9CA29Q34039712-14D99BD0-118D-4018-859B-B2B5E9D92866Q34281975-720780C5-C2C5-491F-A8BF-82F61A498D8DQ34445649-73AFD9ED-D398-4473-940C-03B0B8841656Q34938599-08764035-66C2-4129-9486-E82CC1329D44Q35038218-02B5D489-8908-40B3-B452-D10E1A15FA96Q36203144-56DB89D6-6CB7-4E9E-B9D6-7660DDECFE36Q37017344-167B44CB-71FC-447F-BCF0-89C6BE5EFC9AQ37693967-B810C593-EF80-45D4-BF85-44C3738B35BAQ38095562-B7F092E2-B406-4DF3-AAF3-A9E48541DBD7Q41964597-29E72BCB-7FBB-49D2-B6B2-DD64BF6D6E35Q46102412-5A617F4B-AB66-4ABA-9D94-D5BD78722614
P2860
Comparison of nebulised salbutamol and ipratropium bromide with salbutamol alone in the treatment of chronic obstructive pulmonary disease.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Comparison of nebulised salbut ...... obstructive pulmonary disease.
@en
type
label
Comparison of nebulised salbut ...... obstructive pulmonary disease.
@en
prefLabel
Comparison of nebulised salbut ...... obstructive pulmonary disease.
@en
P2093
P2860
P356
P1433
P1476
Comparison of nebulised salbut ...... obstructive pulmonary disease.
@en
P2093
P2860
P304
P356
10.1136/THX.50.8.834
P407
P577
1995-08-01T00:00:00Z